| Jean Marc Guitton, MD | |
|
840 Stevens Creek Road, Augusta, GA 30907 | |
| (706) 722-6957 | |
| (706) 722-7454 |
| Full Name | Jean Marc Guitton |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 34 Years |
| Location | 840 Stevens Creek Road, Augusta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114979242 | NPI | - | NPPES |
| G48634 | Medicaid | SC | |
| P00393603 | Other | GA | RAILROAD MEDICARE |
| 000885596D | Medicaid | GA | |
| 000885596E | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 048634 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital | Augusta, GA | Hospital |
| Doctors Hospital | Augusta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umg Neurosurgery Llc | 7517187164 | 20 |
| Piedmont Providers Llc | 9830082825 | 371 |
News Archive
OrbiMed, a leading investment management firm focused on the healthcare sector, is pleased to announce the launch of its next venture capital fund, Caduceus Private Investments IV, LP, with $550 million in limited partner commitments. Approximately 80% of the new fund's capital is from returning investors, and the fund's partners include some of the largest pension plans, endowments, foundations, and sovereign funds globally.
In an episode of Al Jazeera's "Inside Story," presenter Shiulie Ghosh and guests Chandra Bhushan, a climate change scientist and deputy director of the Centre for Science and Environment; Deborah Doane, the director of the World Development Movement and a specialist on corporate power who also blogs on food politics; and Philip Thornton of the Consultative Group on International Agricultural Research (CGIAR) examine the politics of global food security.
A previous study in by Choi et al in the USA showed that people with a higher vitamin C intake have a lower risk of gout. There are also studies in healthy volunteers that suggest that vitamin C supplements reduce blood uric acid levels.
NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive investment agreements for a $16 million financing round led by certain of its existing investors with the participation of new investors, including The Elias Group.
The Institute of Medicine of the National Academies "is urging stronger regulation of pharmaceuticals around the world to combat the growing problem of fake and poor-quality medicines," NPR's "Shots" blog reports.
› Verified 2 days ago
| Entity Name | Piedmont Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548273592 PECOS PAC ID: 9830082825 Enrollment ID: O20040204000321 |
News Archive
OrbiMed, a leading investment management firm focused on the healthcare sector, is pleased to announce the launch of its next venture capital fund, Caduceus Private Investments IV, LP, with $550 million in limited partner commitments. Approximately 80% of the new fund's capital is from returning investors, and the fund's partners include some of the largest pension plans, endowments, foundations, and sovereign funds globally.
In an episode of Al Jazeera's "Inside Story," presenter Shiulie Ghosh and guests Chandra Bhushan, a climate change scientist and deputy director of the Centre for Science and Environment; Deborah Doane, the director of the World Development Movement and a specialist on corporate power who also blogs on food politics; and Philip Thornton of the Consultative Group on International Agricultural Research (CGIAR) examine the politics of global food security.
A previous study in by Choi et al in the USA showed that people with a higher vitamin C intake have a lower risk of gout. There are also studies in healthy volunteers that suggest that vitamin C supplements reduce blood uric acid levels.
NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive investment agreements for a $16 million financing round led by certain of its existing investors with the participation of new investors, including The Elias Group.
The Institute of Medicine of the National Academies "is urging stronger regulation of pharmaceuticals around the world to combat the growing problem of fake and poor-quality medicines," NPR's "Shots" blog reports.
› Verified 2 days ago
| Entity Name | Umg Neurosurgery Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437563467 PECOS PAC ID: 7517187164 Enrollment ID: O20141001002556 |
News Archive
OrbiMed, a leading investment management firm focused on the healthcare sector, is pleased to announce the launch of its next venture capital fund, Caduceus Private Investments IV, LP, with $550 million in limited partner commitments. Approximately 80% of the new fund's capital is from returning investors, and the fund's partners include some of the largest pension plans, endowments, foundations, and sovereign funds globally.
In an episode of Al Jazeera's "Inside Story," presenter Shiulie Ghosh and guests Chandra Bhushan, a climate change scientist and deputy director of the Centre for Science and Environment; Deborah Doane, the director of the World Development Movement and a specialist on corporate power who also blogs on food politics; and Philip Thornton of the Consultative Group on International Agricultural Research (CGIAR) examine the politics of global food security.
A previous study in by Choi et al in the USA showed that people with a higher vitamin C intake have a lower risk of gout. There are also studies in healthy volunteers that suggest that vitamin C supplements reduce blood uric acid levels.
NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive investment agreements for a $16 million financing round led by certain of its existing investors with the participation of new investors, including The Elias Group.
The Institute of Medicine of the National Academies "is urging stronger regulation of pharmaceuticals around the world to combat the growing problem of fake and poor-quality medicines," NPR's "Shots" blog reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jean Marc Guitton, MD Po Box 204630, Augusta, GA 30917-4630 Ph: (706) 722-6957 | Jean Marc Guitton, MD 840 Stevens Creek Road, Augusta, GA 30907 Ph: (706) 722-6957 |
News Archive
OrbiMed, a leading investment management firm focused on the healthcare sector, is pleased to announce the launch of its next venture capital fund, Caduceus Private Investments IV, LP, with $550 million in limited partner commitments. Approximately 80% of the new fund's capital is from returning investors, and the fund's partners include some of the largest pension plans, endowments, foundations, and sovereign funds globally.
In an episode of Al Jazeera's "Inside Story," presenter Shiulie Ghosh and guests Chandra Bhushan, a climate change scientist and deputy director of the Centre for Science and Environment; Deborah Doane, the director of the World Development Movement and a specialist on corporate power who also blogs on food politics; and Philip Thornton of the Consultative Group on International Agricultural Research (CGIAR) examine the politics of global food security.
A previous study in by Choi et al in the USA showed that people with a higher vitamin C intake have a lower risk of gout. There are also studies in healthy volunteers that suggest that vitamin C supplements reduce blood uric acid levels.
NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive investment agreements for a $16 million financing round led by certain of its existing investors with the participation of new investors, including The Elias Group.
The Institute of Medicine of the National Academies "is urging stronger regulation of pharmaceuticals around the world to combat the growing problem of fake and poor-quality medicines," NPR's "Shots" blog reports.
› Verified 2 days ago
Dr. William John Woodall, MD, MPH Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1120 15th St Bi 3088, Augusta, GA 30912 Phone: 706-721-0335 | |
Dr. Jose A Santiago, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1 Freedom Way, Va Medical Center, Neurosurgery, Augusta, GA 30904 Phone: 706-733-0188 Fax: 706-823-1751 | |
Dr. Scott Y Rahimi, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Bi-3088, Augusta, GA 30912 Phone: 706-721-4581 | |
Dr. Cole A. Giller, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-4581 | |
John Vender, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-3071 Fax: 706-721-8084 | |
Muhammad Salman Ali, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623 Fax: 706-721-1459 |